Plasma immunoreactive beta-endorphin response to glucose ingestion in human obesity.
Following the oral administration of 100 g of glucose, morbidly-obese subjects and non-obese controls demonstrated increased levels of plasma immunoreactive beta-endorphin. There was a slow rise in plasma immunoreactive beta-endorphin in the non-obese controls throughout the 3-h observation period. The obese subjects demonstrated a delayed and significantly greater rise of plasma immunoreactive beta-endorphin, when compared to the controls. These findings may have implications for further research in human obesity.
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D004723:Endorphins / Q000097:blood*; D005260:Female; D005947:Glucose / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D008297:Male; D009765:Obesity / Q000097:blood*; D001615:beta-Endorphin
D001786:Blood Glucose; D004723:Endorphins; D001615:beta-Endorphin; D005947:Glucose